Clinical trial insights at BIO Asia-Taiwan
Marinova will be attending the Asia Healthcare & Medical Cosmetology Expo, part of BIO Asia-Taiwan in Taipei from July 16-19. Read more
Latest news
Breakthrough in immunochemotherapy research
Recently published research has introduced FINAL (Fucoidan-docetaxel Immunomodulatory Nanoparticles as an Antitumoral Lancer), an innovative nanoplatform with the potential to address multiple cancer types. Read more
Laboratory expertise expands
Marinova welcomes Meegan Grubb to the position of Analytical Chemist. Read more
Commercial extracts assessed
In a new study, four commercial fucoidan extracts were independently characterised to determine their chemical composition, structural features and bioactivities. Read more
Colorectal cancer: Nanoparticles
A new review paper explores the potential of fucoidan-based nanoparticles to support future colorectal cancer treatments. Read more